| Patents for C07D 235 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings (15,325) |
|---|
| 03/02/2005 | EP1509497A1 Calcium receptor modulating arylalkylamines |
| 03/02/2005 | EP1509213A2 Acetamides and benzamides that are useful in treating sexual dysfunction |
| 03/02/2005 | CN1589153A Preventives/remedies for urinary disturbance |
| 03/02/2005 | CN1191240C Nitrogen monoxide synthase inhibitor, its preparation method and application |
| 02/24/2005 | WO2005016888A1 Probe for diseases wth amyloid accumulation, amyloid-staining agent, remedy and preventive for diseases with amyloid accumulation and diagnostic probe and staining agent for neurofibrillary change |
| 02/24/2005 | WO2005016862A1 Substituted arylalkanoic acid derivative and use thereof |
| 02/24/2005 | WO2005016384A1 Probe for disease with amyloid deposit, amyloid-staining agent, remedy and preventive for disease with amyloid deposit and diagnostic probe and staining agent for neurofibril change |
| 02/24/2005 | WO2005016344A1 Piperazine derivatives for the treatment of hiv infections |
| 02/24/2005 | US20050043385 Hydroxyalkylindole derivatives as anticancer agent |
| 02/24/2005 | US20050043379 Leukotriene hydrolase inhibitors; antiinflammatory agents; antihistamines; chronic onstructive pulmonary disorders; atherosclerosis; multiple sclerosis; inflammatory bowel disorders; antiarthritic agents ;psoriasis |
| 02/24/2005 | US20050043378 LTA4H modulators |
| 02/24/2005 | US20050043371 Aminoalcohol derivatives and their use as beta 3 adrenergic agonists |
| 02/24/2005 | US20050043366 Antiinflamamtory agents; immunology disorders; autoimmune diseases; antiallergens; aids viricides; antiarthritic agents; muscular disorders; Parkinson's disease; Alzheimer's disease; kidney damage |
| 02/24/2005 | US20050043304 Lower alkyl molecular weight amine as enzyme inhibitors for use in the treatment of tryptase enzyme inhibitors inhibitorsfor respiratory system disorders, antiinflammatory agents, inflammatory bowel disease, hyperprolific skin disorders, vascular edema and rheumatoid arthritis |
| 02/24/2005 | US20050043300 Piperazine derivatives |
| 02/24/2005 | CA2535665A1 Substituted arylalkanoic acid derivative and use thereof |
| 02/24/2005 | CA2534866A1 Piperazine derivatives for the treatment of hiv infections |
| 02/24/2005 | CA2500358A1 Probes for diseases in which amyloid accumulates, agents for staining amyloid, drugs for treatment and prophylaxis of diseases with accumulated amyloid, and probes for diagnosis of neurofibrillary tangles and agents for staining neurofibrillary tangles |
| 02/23/2005 | EP1507541A2 Inhibitors and methods of use thereof |
| 02/23/2005 | EP1507504A1 Cycloalkyl inhibitors of potassium channel function |
| 02/23/2005 | EP0876337B1 New lh-rh antagonists with improved effectiveness |
| 02/23/2005 | CN1585746A Beta-amyloid protein production/secretion inhibitors |
| 02/23/2005 | CN1585638A Linked biaryl compounds |
| 02/22/2005 | US6858739 Indole and benzimidazole 15-lipoxygenase inhibitors |
| 02/22/2005 | US6858630 Administering substituted naphthimidazole derivative for therapy of thrombocytopenia |
| 02/22/2005 | CA2218493C Benzimidazole compounds and their use as modulators of the gabaa receptor complex |
| 02/22/2005 | CA2129039C Tri-substituted phenyl derivatives as phosphodiesterase inhibitors |
| 02/17/2005 | WO2005014555A1 4,5-dihydro-imidazole as p2x7 ion channel blockers |
| 02/17/2005 | WO2004099131A3 Compounds having a fused, bicyclic moiety for binding to the minor groove of dsdna |
| 02/17/2005 | WO2004092115A3 Hydroxamates as therapeutic agents |
| 02/17/2005 | US20050038095 Azolylbenzamides and analogues and their use for treating osteoporosis |
| 02/17/2005 | US20050038069 Tumor necrosis factor antagonist; antiinflammatory agents; such as 2-Cyclopropyl-4-(3,5-dimethyl-4-pyridylmethoxy)-7-methoxy-3H-benzimidazole |
| 02/17/2005 | US20050038067 A compound with azo containing mono and a bicyclic rings attached with an aryl or heteroaryl ring; both therapeutic and diagnostic |
| 02/17/2005 | US20050038027 Melanocortin-4 receptor agonists; obesity, type II diabetes; such as N-(2-(2-(2,4-dichlorophenyl)ethyl)-1-oxo-2,3-dihydro-1H-isoindol-5-yl) -3-methyl-N'-(2,6,6-trimethylbicyclo(3.1.1)hept-3yl)piperazine-1-carboximidamide |
| 02/17/2005 | US20050038022 Using a benzimidazole carbamate compound in lipid carrier; antitumor agents |
| 02/17/2005 | US20050037931 Reaction products of mercaptobenzothiazoles, mercaptothiazolines, and mercaptobenzimidazoles with epoxides as lubricant additives |
| 02/17/2005 | CA2534292A1 Substituted imidazopyrimidines for the prevention and treatment of cancer |
| 02/17/2005 | CA2532910A1 4,5-dihydro-imidazole as p2x7 ion channel blockers |
| 02/16/2005 | EP1506178A2 Bicyclic modulators of androgen receptor function |
| 02/15/2005 | US6855719 Nitrogen compounds such as 2-(3-Chloroanilino)-4-(2-methyl-imidazo(1,2a)pyrid-3-yl)pyrimidine, used as cyclin dependent kinase inhibitors or as anticarcinogenic agents |
| 02/15/2005 | US6855715 Drugs such as 1-(3-Amino-4-chlorobenzoyl-D-phenylglycinyl)-4-(4-fluoro-2 -methylsulphonylphenyl)piperazine, used as anticoagulants |
| 02/15/2005 | US6855714 For therapy of inflammatory, allergic, infectious or autoimmune diseases |
| 02/15/2005 | US6855713 Benzimidazole derivatives, a process for their manufacture and use as a medicine |
| 02/10/2005 | WO2005012297A1 Benzimidazole, benzthiazole and benzoxazole derivatives and their use as lta4h modulators |
| 02/10/2005 | WO2005012296A1 Benzimidazole, benzthiazole and benzoxazole derivatives and their use as lta4h modulators |
| 02/10/2005 | WO2005012245A1 Novel heteroaryl derivative |
| 02/10/2005 | WO2005012228A1 O-coordinated metal chelates and their use in optical recording media having high storage capacity |
| 02/10/2005 | WO2005011646A2 Nitrooxy derivatives of losartan, valsatan, candesartan, telmisartan, eprosartan and olmesartan as angiotensin-ii receptor blockers for the treatment of cardiovascular diseases |
| 02/10/2005 | WO2004107477A3 Conductive membranes formed from silanes having functional groups |
| 02/10/2005 | WO2004103976A3 Method for synthesising heterocyclic compounds from thiourea derivatives |
| 02/10/2005 | US20050032814 Process for production of cyclic diamine compounds or salts thereof |
| 02/10/2005 | US20050032790 For example, 1-(2-Amino-4-chlorobenzoyl-D-phenylglycinyl)-4,4'-bispiperidine; for treatment of thrombosis, emphysema, cirrhosis; antiarthritic agents, anticancer agents, antihistamines |
| 02/10/2005 | US20050029705 Extrusion die |
| 02/10/2005 | CA2534451A1 Angiotensin ii receptor blocker derivatives |
| 02/10/2005 | CA2534212A1 Benzimidazole, benzthiazole and benzoxazole derivatives and their use as lta4h modulators |
| 02/10/2005 | CA2531333A1 Triazolopyrimidine derivatives as glycogen synthase kinase 3 inhibitors |
| 02/09/2005 | EP1505066A1 Polymorph of acid 4-[2-[4-[1-(2-ethoxyethyl)-1h-benzimidazole-2-il]-1-piperidinyl]ethyl]-alpha, alpha-dimethyl-benzeneacetic |
| 02/09/2005 | EP1505063A1 Benzimidazole derivatives |
| 02/09/2005 | EP1414816B1 Stable polymorph of flibanserin, technical process for its preparation and the use thereof for preparing medicaments |
| 02/09/2005 | CN1578772A Crystalline sodium salt of telmisartan and the use of the same as an angiotensin antagonist |
| 02/09/2005 | CN1578663A Inhibitors of histone deacetylase |
| 02/08/2005 | US6852882 N-(2-(N-formyl-N-hydroxyamino)ethyl)arylamides with bacterial polypeptide deformylase inhibiting activity |
| 02/08/2005 | US6852748 Derivatives of 6,7-dihydro-5H-imidazo(1,2- alpha )imidazole-3- sulfonyl)-pyrrolidine-2-carboxylic acid amide which exhibit good inhibitory effect upon the interaction of CAMs and Leukointegrins and are thus useful in the treatment |
| 02/08/2005 | US6852725 Imidazolyl derivatives |
| 02/08/2005 | US6852711 HIV protease inhibitors |
| 02/08/2005 | CA2112081C Imidazole compounds, their preparation and use |
| 02/08/2005 | CA2096525C Retroviral protease inhibitors |
| 02/08/2005 | CA2096409C Retroviral protease inhibitors |
| 02/08/2005 | CA2096408C Retroviral protease inhibitors |
| 02/03/2005 | WO2005009996A1 Sulfonyldihydro- benzimidazolone compounds as 5-hydroxytryptamine-6 ligands |
| 02/03/2005 | WO2005009975A2 Benzimidazole derivatives as mek inhibitors |
| 02/03/2005 | WO2005009941A1 Indane derivates as muscarinic receptor agonists |
| 02/03/2005 | WO2004100881A3 Preparation and use of aryl alkyl acid derivatives for the treatment of obesity |
| 02/03/2005 | WO2004054581A3 Cyclohexyl compounds as ccr5 antagonists |
| 02/03/2005 | US20050026973 New heterocyclic oxime compounds |
| 02/03/2005 | US20050026972 Benzimidazol-or indol-aminoacetonitrile derivatives for parasite control |
| 02/03/2005 | US20050026970 Antiproliferative agents, enzyme inhibitor for treating cancer, restenosis, psoriasis, autoimmune disease, atherosclerosis, osteoarthritis, rheumatoid arthritis, heart failure, chronic pain, and neuropathic pain; chemical synthesis |
| 02/03/2005 | US20050026916 Heterocyclic compounds as P2X7 ion channel blockers |
| 02/03/2005 | DE10330358A1 New arylalkanol derivatives used for treating e.g. respiratory diseases, joint diseases, vascular inflammations, skin disorders, kidney and liver diseases and neurological diseases |
| 02/03/2005 | CA2532071A1 Sulfonyldihydro- benzimidazolone compounds as 5-hydroxytryptamine-6 ligands |
| 02/03/2005 | CA2529036A1 Indane derivates as muscarinic receptor agonists |
| 02/02/2005 | EP1502914A1 Process for the preparation of 1-amino-4-(hydroxymethyl)-2-cyclopentene derivatives |
| 02/02/2005 | EP1502590A1 Heterocyclic oxime derivatives, process for their preparation and use thereof in the treatment of type II diabetes |
| 02/02/2005 | EP1501800A1 Bombesin antagonists |
| 02/02/2005 | EP1501790A2 Novel sodium channel blockers |
| 02/02/2005 | CN1575273A 3, 4-di-substituted cyclobutene-1, 2-diones as CXC-chemokine receptor antagonists |
| 02/02/2005 | CN1575177A Cxcr3 antagonists |
| 02/02/2005 | CN1187337C Thiobenzimidazole derivatives |
| 02/01/2005 | US6849733 Compounds containing amidated guanidine derivative type functional group of structure N-C(=N)-N-CO-N-C=N or N-C(=N)-N-CO-N |
| 01/27/2005 | WO2005007621A2 Ubiquitin ligase inhibitors |
| 01/27/2005 | US20050020575 Sulfonyldihydrobenzimidazolone compounds as 5-hydroxytryptamine-6 ligands |
| 01/26/2005 | EP1499898A2 Regulation of tnf-alpha |
| 01/26/2005 | EP1499305A2 Use of ep4 receptor ligands in the treatment of il-6 involved diseases |
| 01/26/2005 | EP0983267B1 Amidoaromatic ring sulfonamide hydroxamic acid compounds |
| 01/26/2005 | CN1571670A Treating sexual desire disorders with flibanserin |
| 01/26/2005 | CN1186326C Propane-1, 3-dione derivatives |
| 01/25/2005 | US6846833 Vitronectin receptor antagonist bicyclic compounds, preparation method and compositions containing same |
| 01/20/2005 | WO2004100865A3 New benzimidazole derivatives |
| 01/20/2005 | US20050014812 Benzimidazole compounds |
| 01/20/2005 | US20050014811 Such as 4-cyclopentylamino-benzenesulfonic acid 2-(3,4-dimethoxy-phenylamino)-1H-benzoimidazol-5-yl ester; cyclin-dependent kinase inhibitors that are aimed to be more active than flavopiridol |